Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Patient safety systemic fibrosis

In some clinical centers, CE-MRA is not an option anymore for ESRD patients due to the riskto develop nephrotic systemic fibrosis (NSF) [17], although the safety profile ofMR contrast agents with respect to hypersensitivity reactions is very good [42]. [Pg.81]

See other pages where Patient safety systemic fibrosis is mentioned: [Pg.92] [Pg.702] [Pg.301] [Pg.34] [Pg.504] [Pg.275] [Pg.238] [Pg.11] [Pg.220]

See also in sourсe #XX -- [ Pg.56 , Pg.57 , Pg.70 , Pg.71 ]

SEARCH

Systemic fibrosis